Comparıson Of The Effects Of Perıcapsulary Nerve Group Block (Peng Block) And Lumbar Erector Spına Plan Block (Lesp Block) On Postoperatıve Opıoıd Consumptıon
Launched by SAKARYA UNIVERSITY · May 28, 2025
Trial Information
Current as of July 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different types of nerve blocks, called the PENG block and the Lumbar Erector Spinae Plane (ESP) block, to see which one helps reduce pain and the need for opioids (pain medication) after hip surgery in older patients. The researchers believe that the Lumbar ESP block might work better than the PENG block for relieving pain and reducing the amount of opioids patients need after their surgery.
To participate in this trial, you must be over 65 years old and have a hip fracture. However, people with certain conditions, like those who have bleeding disorders or do not want regional anesthesia, will not be eligible. If you join the study, you will receive one of the two nerve blocks before your surgery, and the researchers will monitor your pain levels and opioid use afterward to see which method is more effective. This study aims to improve pain management for older adults after hip surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients with hip fractures
- • over 65 years old
- Exclusion Criteria:
- • long-term surgery
- • Patients who do not want regional anesthesia
- • bleeding disorder disease
- • wound in the operation area
About Sakarya University
Sakarya University is a distinguished academic institution dedicated to advancing scientific research and innovation in healthcare. With a robust commitment to improving patient outcomes, the university actively sponsors clinical trials that explore novel therapeutic approaches and contribute to evidence-based medicine. Leveraging a multidisciplinary team of researchers, clinicians, and scholars, Sakarya University fosters a collaborative environment aimed at enhancing clinical practices and addressing pressing health challenges. Through these initiatives, the university not only enriches the academic landscape but also plays a pivotal role in translating research findings into tangible benefits for society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported